诉讼指控阿登健康公司欺诈和误导性财务报告,导致5.55亿美元的损失和34%的股价下跌. A lawsuit accuses Ardent Health of fraud and misleading financial reports, leading to a $555M loss and a 34% stock drop.

2024年7月至2025年11月期间,对Ardent Health Inc.公司提起了集体诉讼,指控其为证券欺诈和误导性财务披露。 A class action lawsuit has been filed against Ardent Health, Inc., alleging securities fraud and misleading financial disclosures from July 2024 to November 2025. 投诉称,该公司拖延了对无法收账账户的确认,没有为不断上升的渎职索赔和整个行业的费用压力,包括付款人拒绝付款和社会通货膨胀留出足够的准备金,从而夸大了财务结果。 The complaint claims the company inflated its financial results by delaying recognition of uncollectible accounts and failing to set aside adequate reserves for rising malpractice claims and industry-wide cost pressures, including payer denials and social inflation. 这些问题导致了5.55亿美元的损失和与新墨西哥州以往索赔有关的5 400万美元负债准备金的增加。 These issues led to a $555 million loss and a $54 million increase in liability reserves tied to past New Mexico claims. 2025年11月宣布后,Ardent的股票下跌了近34%。 After the November 2025 announcement, Ardent’s stock dropped nearly 34%. 2026年3月9日之前,在该类期间购买股票的投资者可以申请成为主要原告。 Investors who bought shares during the class period may apply to become lead plaintiff by March 9, 2026. 该案正由Robbins Geller Rudman & Dowd LLP处理。 The case is being handled by Robbins Geller Rudman & Dowd LLP.